Featured Research

from universities, journals, and other organizations

In Emergency, Flu Vaccine Could Be Made Quickly In Existing Facilities

Date:
March 24, 2005
Source:
University Of Michigan
Summary:
In an emergency such as a pandemic outbreak or last year's vaccine shortage, the influenza vaccine could be produced twice as fast using cell cultures in existing biopharmaceutical manufacturing facilities, according to Henry Wang, a University of Michigan professor of biomedical and chemical engineering.

ANN ARBOR, Mich. -- In an emergency such as a pandemic outbreak or last year's vaccine shortage, the influenza vaccine could be produced twice as fast using cell cultures in existing biopharmaceutical manufacturing facilities, according to Henry Wang, a University of Michigan professor of biomedical and chemical engineering.

Wang and graduate student Lyle Lash, speaking at the 229th American Chemical Society National Meeting March 13-17, will propose a system for retrofitting existing biopharmaceutical buildings to produce the flu vaccine using cell cultures. The plan would require proper government and industry support and some advanced planning and training.

Wang and Lash first did a case study of traditional vaccine manufacturing, where the virus is injected and incubated in a chicken egg, killed and extracted, then bottled and sold. The process takes more than four months.

Next, the researchers considered the cell-based vaccines. In the cell culture approach, the flu virus incubates in cell cultures rather than in eggs. Several companies are trying to perfect the cell-based flu vaccines where cells are grown in large vats. It is seen as a promising approach because it's more flexible and quicker than the current egg culture method.

By building a separate cell culture facility and shipping the cell to the existing biomanufacturing plants (assuming they have agreed in advance to participate), the production cycle could be cut in half to two months, Wang said.

Lash and Wang identified approximately a dozen potential facilities around the world that are large scale FDA and GMP (good manufacturing practices) approved facilities that could potentially be modified to manufacture flu vaccines in an emergency.

Many biopharmaceutical facilities use mammalian cell culture already to produce their drug products so they could easily be switched to producing flu vaccine using the same bioreactors, the researchers argue. Long term, it might be necessary to standardize the production systems at facilities in the network to ensure consistency in the vaccine manufacturing process.

An influenza emergency is nearly inevitable, experts say. All the factors exist for a major flu pandemic: new, extremely aggressive viruses with new ways of spreading, and insufficient vaccine supplies. A Jan. 24 flu symposium hosted by the U-M School of Public Health's Michigan Center for Public Health Preparedness and the Michigan Department of Community Health discussed this threat in-depth. Visit: http://www.umich.edu/news/index.html?Releases/2005/Feb05/flu

To reduce the time required to expand the cells to production scale, a small GMP cell culture facility could maintain the cells and expand in the face of a crisis, ready to provide them as seeds to the facilities that will help manufacture the vaccine, Lash said.

"We feel that this facility would work well as part of a university or training center that could be operated by students gaining valuable experience in biopharmaceutical manufacturing, and keep us prepared to respond to an emergency," Lash said.

Funding to build this facility and set up this network could come from the government or companies that are willing to be a part of the network, Lash said.

"There are several scientific and regulatory issues to manufacturing the vaccine using this network concept so we will apply for funding to address the scientific issues to enable such a facility and network to be built in the future," Lash said.

Economically, the use of cell culture to produce the vaccine is comparable to that of egg culture. It is more expensive to build a new large cell culture facility to produce the vaccine than a new egg culture facility so the use of existing cell culture facilities would be advantageous.

The next step is to continue research to identify and address the technical issues, such as ensuring consistent good growth of cells shipped for different times to different facilities, and ensuring that the cells are not contaminated.

For information on Wang, see: http://www.engin.umich.edu/dept/cheme/people/wang.html

For ACS, see: http://www.chemistry.org/portal/a/c/s/1/home.html

For College of Engineering, see: http://www.engin.umich.edu/


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "In Emergency, Flu Vaccine Could Be Made Quickly In Existing Facilities." ScienceDaily. ScienceDaily, 24 March 2005. <www.sciencedaily.com/releases/2005/03/050323133243.htm>.
University Of Michigan. (2005, March 24). In Emergency, Flu Vaccine Could Be Made Quickly In Existing Facilities. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2005/03/050323133243.htm
University Of Michigan. "In Emergency, Flu Vaccine Could Be Made Quickly In Existing Facilities." ScienceDaily. www.sciencedaily.com/releases/2005/03/050323133243.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins